Fox Chase Cancer Center News

PHILADELPHIA (April 9, 2019) – Tomoki Makino, MD, PhD, an assistant professor of gastrointestinal surgery at Osaka University in Japan, spent the first week of April learning about the American surgical system as a visiting surgeon at Fox Chase Cancer Center.

PHILADELPHIA (April 4, 2019) — Igor Astsaturov, MD, PhD, co-leader of the Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, received a grant from the Pancreatic Cancer Action Network to support research into potential new therapies for pancreatic cancer.

PHILADELPHIA (April 2, 2019) – Some of the most common drugs used to target cancer cells may also have unintended effects on cells throughout the entire body by affecting a signaling “antenna” that cells use to send and receive information, according to new research from scientists at Fox Chase Cancer Center.

PHILADELPHIA (April 1, 2019) – Fox Chase Cancer Center seeks to raise awareness about symptoms and risk factors for head and neck cancer. Head and neck cancer is used to describe many malignant tumors that develop in or around the throat, larynx (voice box), nose, sinuses and mouth.

PHILADELPHIA (March 28, 2019) — With support from the National Cancer Institute, Camille Ragin, PhD, MPH, and colleagues are building a cancer research infrastructure in the Caribbean to prepare the region to reduce its cancer burden.

PHILADELPHIA (March 28, 2019) — More than 36 percent of breast cancer patients transfer their care to new providers, incurring the risk that surgery and other treatments will be delayed, increasing the likelihood they will neglect recommendations for timely treatment.

PHILADELPHIA (March 18, 2019) — Fox Chase Cancer Center is pleased to announce its continuing support for the Colon Cancer Coalition’s Annual Get Your Rear in Gear run/walk. Faculty, staff, volunteers, patients, survivors, and their families will come together as members of the Fox Chase team on Sunday, March 24.

PHILADELPHIA (March 11, 2019) — Adhesion of lymphocytes to their cellular targets is critical to adaptive immunity, the body’s ability to assign specific antibodies to pathogens. RAP1 function can be suppressed if its effector protein (RIAM) adopts an autoinhibitory configuration, and this suppression of RAP1 function is released once RIAM is phosphorylated.